These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 33095997)
1. Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases. Deng Z; Kalin GT; Shi D; Kalinichenko VV Am J Respir Cell Mol Biol; 2021 Mar; 64(3):292-307. PubMed ID: 33095997 [TBL] [Abstract][Full Text] [Related]
2. Biocomposite-based nanostructured delivery systems for the treatment and control of inflammatory lung diseases. Mukherjee D; Bhatt S Nanomedicine (Lond); 2022 May; 17(12):845-863. PubMed ID: 35477308 [TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-based therapy for respiratory diseases. Da Silva AL; Santos RS; Xisto DG; Alonso Sdel V; Morales MM; Rocco PR An Acad Bras Cienc; 2013 Mar; 85(1):137-46. PubMed ID: 23460424 [TBL] [Abstract][Full Text] [Related]
4. Mesoporous silica nanoparticles for pulmonary drug delivery. García-Fernández A; Sancenón F; Martínez-Máñez R Adv Drug Deliv Rev; 2021 Oct; 177():113953. PubMed ID: 34474094 [TBL] [Abstract][Full Text] [Related]
5. Targeting therapeutics to the glomerulus with nanoparticles. Zuckerman JE; Davis ME Adv Chronic Kidney Dis; 2013 Nov; 20(6):500-7. PubMed ID: 24206602 [TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-based delivery system for application of siRNA in vivo. Wang Y; Li Z; Han Y; Liang LH; Ji A Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287 [TBL] [Abstract][Full Text] [Related]
7. Nanomedicine for the management of lung and blood diseases. Buxton DB Nanomedicine (Lond); 2009 Apr; 4(3):331-9. PubMed ID: 19331540 [TBL] [Abstract][Full Text] [Related]
8. Application of nanotechnology in drug delivery systems for respiratory diseases (Review). Luo MX; Hua S; Shang QY Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125 [TBL] [Abstract][Full Text] [Related]
9. Nanomedicine in pulmonary delivery. Mansour HM; Rhee YS; Wu X Int J Nanomedicine; 2009; 4():299-319. PubMed ID: 20054434 [TBL] [Abstract][Full Text] [Related]
10. Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma. de la Puente P; Azab AK Eur J Haematol; 2017 Jun; 98(6):529-541. PubMed ID: 28208215 [TBL] [Abstract][Full Text] [Related]
11. Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy. Jin Z; Gao Q; Wu K; Ouyang J; Guo W; Liang XJ Adv Drug Deliv Rev; 2023 Nov; 202():115111. PubMed ID: 37820982 [TBL] [Abstract][Full Text] [Related]
12. Lipid-Based Nanoparticle Functionalization with Coiled-Coil Peptides for Aschmann D; Knol RA; Kros A Acc Chem Res; 2024 Apr; 57(8):1098-1110. PubMed ID: 38530194 [TBL] [Abstract][Full Text] [Related]
13. Disposition of nanoparticle-based delivery system via inner ear administration. Chen G; Zhang X; Yang F; Mu L Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174 [TBL] [Abstract][Full Text] [Related]
14. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine. Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Pridgen EM; Langer R; Farokhzad OC Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029 [TBL] [Abstract][Full Text] [Related]
16. Polymeric nanoparticles in development for treatment of pulmonary infectious diseases. Lim YH; Tiemann KM; Hunstad DA; Elsabahy M; Wooley KL Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):842-871. PubMed ID: 27016134 [TBL] [Abstract][Full Text] [Related]
17. Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? Auffinger B; Morshed R; Tobias A; Cheng Y; Ahmed AU; Lesniak MS Oncotarget; 2013 Mar; 4(3):378-96. PubMed ID: 23594406 [TBL] [Abstract][Full Text] [Related]
18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
19. Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy. Swetledge S; Jung JP; Carter R; Sabliov C J Nanobiotechnology; 2021 Jan; 19(1):10. PubMed ID: 33413421 [TBL] [Abstract][Full Text] [Related]
20. Cell-specific drug targeting in the lung. Abed S; Turner R; Serniuck N; Tat V; Naiel S; Hayat A; Mekhael O; Vierhout M; Ask K; Rullo AF Biochem Pharmacol; 2021 Aug; 190():114577. PubMed ID: 33887259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]